PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Demonstrated efficacy in treating hyperlipidemia in rat models, influencing metabolic networks and serum biomarkers [PMID:36097410, PMID:32730873]
Total flavonoids significantly reduced liver index, spleen index, and serum transaminases (ALT, AST) in CCl4-induced liver fibrosis rat models [PMID:18812033]
Extract showed in vitro and in vivo inhibitory effects on U14 tumor growth, with a 70.44% inhibition rate at 80µg/L in vitro [PMID:24146503]
In vitro inhibitory effects with IC50 values of 14.80 µg/mL (HepG2) and 13.50 µg/mL (Hela) [PMID:24146487]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 26357619 (2014) — Traditional Chinese Medicine Induced Liver Injury. · Journal of clinical and translational hepatology
- 2.PMID: 36097410 (2023) — Overall metabolic network analysis of urine in hyperlipidemic rats treated with Bidens bipinnata L. · Biomedical chromatography : BMC
- 3.PMID: 32730873 (2020) — Serum metabonomics coupled with HPLC-LTQ/orbitrap MS and multivariate data analysis on the ameliorative effects of Bidens bipinnata L. in hyperlipidemic rats. · Journal of ethnopharmacology
- 4.PMID: 25536637 (2015) — Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases. · Annals of hepatology
- 5.PMID: 24146503 (2013)